Intravenous Ketamine for Cancer Pain Management, Including Flares During the COVID-19 Pandemic: A Retrospective Study.
Daniel Chun-Suk OhPaul HaffeyAnkur PatelAmitabh GulatiPublished in: Pain medicine (Malden, Mass.) (2021)
Intravenous ketamine may be a safe and effective adjuvant treatment for CNP, especially with serotonin-norepinephrine reuptake inhibitors. Larger, prospective studies are warranted and should explore parameters to help prognosticate response to ketamine infusions.